Protective effect of whey proteins against nonalcoholic fatty liver in rats - PubMed (original) (raw)
Protective effect of whey proteins against nonalcoholic fatty liver in rats
Essam M Hamad et al. Lipids Health Dis. 2011.
Abstract
Background: Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome and can vary from hepatic steatosis to end-stage liver disease. It is the most common liver disease and its prevalence is increasing worldwide. In the present study, the effect of whey proteins on some parameters of NAFLD was investigated.
Results: Oral administration of the studied whey proteins products reduced the final body weight of rats. There was a significant reduction effect (P<0.05) of the tested proteins on hepatic triglycerides, liver enzymes (ALT and AST), lipid peroxidation (malondialdehyde level) and serum glucose. Feeding on whey proteins caused an increase in the reduced glutathione. Hepatic content of reduced glutathione was not affected by any of the used whey proteins, but it showed an increasing tendency (P>0.05). Liver histology showed an improvement of fatty infiltration in hepatocytes from whey protein groups and gives the histology of liver a normal appearance.
Conclusions: The obtained results indicate a possible role for oral administration of whey proteins in the regulation of liver biochemistries in a rat's model of NAFLD. This regulatory effect of whey proteins was accompanied by an improvement in fatty infiltration in hepatocytes and a reduction of oxidative stress parameters.
Figures
Figure 1
Effect of oral administration of whey proteins products on serum alanine transaminase (ALT) and aspartate transaminase (AST) in rats fed the normal and high carbohydrate, fat free diets.
Figure 2
Effect of oral administration of whey proteins products on the histological examination of livers from rats fed high carbohydrate, fat free diet for 4 weeks. Control; basal diet group, WPI; whey protein isolate group, WPH; whey protein hydrolysate group, αLA; alpha lactalbumin group, βLG; beta lactoglobulin group and GMP; glycomacropeptide group. Arrows show numerous spherical vacuoles of fat droplets.
Similar articles
- Acetyl-L-carnitine and lipoic acid improve mitochondrial abnormalities and serum levels of liver enzymes in a mouse model of nonalcoholic fatty liver disease.
Kathirvel E, Morgan K, French SW, Morgan TR. Kathirvel E, et al. Nutr Res. 2013 Nov;33(11):932-41. doi: 10.1016/j.nutres.2013.08.001. Epub 2013 Sep 18. Nutr Res. 2013. PMID: 24176233 - Pentoxifylline and melatonin in combination with pioglitazone ameliorate experimental non-alcoholic fatty liver disease.
Zaitone S, Hassan N, El-Orabi N, El-Awady el-S. Zaitone S, et al. Eur J Pharmacol. 2011 Jul 15;662(1-3):70-7. doi: 10.1016/j.ejphar.2011.04.049. Epub 2011 Apr 30. Eur J Pharmacol. 2011. PMID: 21549113 - Preparation and Evaluation of Functional Foods for Prevention of Non-alcoholic Fatty Liver Disease.
A Mohamed D, S Abdelgayed S, A Essa H, S Mohamed R. A Mohamed D, et al. Pak J Biol Sci. 2018 Jan;21(9):454-462. doi: 10.3923/pjbs.2018.454.462. Pak J Biol Sci. 2018. PMID: 30724047 - Combined treatments with metformin and phosphodiesterase inhibitors alleviate nonalcoholic fatty liver disease in high-fat diet fed rats: a comparative study.
Heeba GH, El-Deen RM, Abdel-Latif RG, Khalifa MMA. Heeba GH, et al. Can J Physiol Pharmacol. 2020 Aug;98(8):498-505. doi: 10.1139/cjpp-2019-0487. Epub 2020 Feb 21. Can J Physiol Pharmacol. 2020. PMID: 32083947 - Camel milk ameliorates steatohepatitis, insulin resistance and lipid peroxidation in experimental non-alcoholic fatty liver disease.
Korish AA, Arafah MM. Korish AA, et al. BMC Complement Altern Med. 2013 Oct 13;13:264. doi: 10.1186/1472-6882-13-264. BMC Complement Altern Med. 2013. PMID: 24119413 Free PMC article.
Cited by
- Whey protein supplementation reduced the liver damage scores of rats fed with a high fat-high fructose diet.
Yiğit Ziolkowski A, Şenol N, Aslankoç R, Samur G. Yiğit Ziolkowski A, et al. PLoS One. 2024 Apr 4;19(4):e0301012. doi: 10.1371/journal.pone.0301012. eCollection 2024. PLoS One. 2024. PMID: 38573884 Free PMC article. - The Effect of Bioactive Aliment Compounds and Micronutrients on Non-Alcoholic Fatty Liver Disease.
Munteanu C, Schwartz B. Munteanu C, et al. Antioxidants (Basel). 2023 Apr 10;12(4):903. doi: 10.3390/antiox12040903. Antioxidants (Basel). 2023. PMID: 37107278 Free PMC article. Review. - Protective effect of protein hydrolysates from Litopenaeus vannamei waste on oxidative status, glucose regulation, and autophagy genes in non-alcoholic fatty liver disease in Wistar rats.
Hadavi M, Najdegerami EH, Nikoo M, Nejati V. Hadavi M, et al. Iran J Basic Med Sci. 2022 Aug;25(8):954-963. doi: 10.22038/IJBMS.2022.62167.13761. Iran J Basic Med Sci. 2022. PMID: 36159326 Free PMC article. - Changes in Histological Structure, Interleukin 12, Smooth Muscle Actin and Nitric Oxide Synthase 1. and 3. Expression in the Liver of Running and Non-Running Wistar Rats Supplemented with Bee Pollen or Whey Protein.
Jarosz PM, Jasielski PP, Zarobkiewicz MK, Sławiński MA, Wawryk-Gawda E, Jodłowska-Jędrych B. Jarosz PM, et al. Foods. 2022 Apr 14;11(8):1131. doi: 10.3390/foods11081131. Foods. 2022. PMID: 35454718 Free PMC article. - Whey Protein Supplementation Improves the Glycemic Response and May Reduce Non-Alcoholic Fatty Liver Disease Related Biomarkers in Women with Polycystic Ovary Syndrome (PCOS).
Zumbro EL, Rao M, Balcom-Luker S, Broughton KS, LeMieux MJ. Zumbro EL, et al. Nutrients. 2021 Jul 17;13(7):2451. doi: 10.3390/nu13072451. Nutrients. 2021. PMID: 34371959 Free PMC article.
References
- Nahmias P. PAA conference. New Orleans, USA; 2008. Trends in the prevalence of overweight among women in Egypt.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources